These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9634701)

  • 1. Solution structure of the heparin-binding domain of vascular endothelial growth factor.
    Fairbrother WJ; Champe MA; Christinger HW; Keyt BA; Starovasnik MA
    Structure; 1998 May; 6(5):637-48. PubMed ID: 9634701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF.
    Keck RG; Berleau L; Harris R; Keyt BA
    Arch Biochem Biophys; 1997 Aug; 344(1):103-13. PubMed ID: 9244387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency.
    Keyt BA; Berleau LT; Nguyen HV; Chen H; Heinsohn H; Vandlen R; Ferrara N
    J Biol Chem; 1996 Mar; 271(13):7788-95. PubMed ID: 8631822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
    Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
    J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refinement of the solution structure of the heparin-binding domain of vascular endothelial growth factor using residual dipolar couplings.
    Stauffer ME; Skelton NJ; Fairbrothe WJ
    J Biomol NMR; 2002 May; 23(1):57-61. PubMed ID: 12061718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structure of the VEGF-binding domain of Flt-1: comparison of its free and bound states.
    Starovasnik MA; Christinger HW; Wiesmann C; Champe MA; de Vos AM; Skelton NJ
    J Mol Biol; 1999 Oct; 293(3):531-44. PubMed ID: 10543948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: multiple copy flexibility and receptor binding.
    Muller YA; Christinger HW; Keyt BA; de Vos AM
    Structure; 1997 Oct; 5(10):1325-38. PubMed ID: 9351807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor.
    Dougher AM; Wasserstrom H; Torley L; Shridaran L; Westdock P; Hileman RE; Fromm JR; Anderberg R; Lyman S; Linhardt RJ; Kaplan J; Terman BI
    Growth Factors; 1997; 14(4):257-68. PubMed ID: 9386990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms.
    Gengrinovitch S; Greenberg SM; Cohen T; Gitay-Goren H; Rockwell P; Maione TE; Levi BZ; Neufeld G
    J Biol Chem; 1995 Jun; 270(25):15059-65. PubMed ID: 7797488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a soluble vascular endothelial growth factor receptor-immunoglobulin chimera.
    Kaplan JB; Sridharan L; Zaccardi JA; Dougher-Vermazen M; Terman BI
    Growth Factors; 1997; 14(4):243-56. PubMed ID: 9386989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the complex between VEGF and a receptor-blocking peptide.
    Wiesmann C; Christinger HW; Cochran AG; Cunningham BC; Fairbrother WJ; Keenan CJ; Meng G; de Vos AM
    Biochemistry; 1998 Dec; 37(51):17765-72. PubMed ID: 9922142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain.
    Mamluk R; Gechtman Z; Kutcher ME; Gasiunas N; Gallagher J; Klagsbrun M
    J Biol Chem; 2002 Jul; 277(27):24818-25. PubMed ID: 11986311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165.
    Soker S; Gollamudi-Payne S; Fidder H; Charmahelli H; Klagsbrun M
    J Biol Chem; 1997 Dec; 272(50):31582-8. PubMed ID: 9395496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A set of loop-1 and -3 structures in the novel vascular endothelial growth factor (VEGF) family member, VEGF-ENZ-7, is essential for the activation of VEGFR-2 signaling.
    Kiba A; Yabana N; Shibuya M
    J Biol Chem; 2003 Apr; 278(15):13453-61. PubMed ID: 12551914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor.
    Wiesmann C; Fuh G; Christinger HW; Eigenbrot C; Wells JA; de Vos AM
    Cell; 1997 Nov; 91(5):695-704. PubMed ID: 9393862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors.
    Tessler S; Rockwell P; Hicklin D; Cohen T; Levi BZ; Witte L; Lemischka IR; Neufeld G
    J Biol Chem; 1994 Apr; 269(17):12456-61. PubMed ID: 8175651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallization of the receptor binding domain of vascular endothelial growth factor.
    Christinger HW; Muller YA; Berleau LT; Keyt BA; Cunningham BC; Ferrara N; de Vos AM
    Proteins; 1996 Nov; 26(3):353-7. PubMed ID: 8953654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alpha-helical domain near the amino terminus is essential for dimerization of vascular endothelial growth factor.
    Siemeister G; Marmé D; Martiny-Baron G
    J Biol Chem; 1998 May; 273(18):11115-20. PubMed ID: 9556597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells.
    Fiebich BL; Jäger B; Schöllmann C; Weindel K; Wilting J; Kochs G; Marmé D; Hug H; Weich HA
    Eur J Biochem; 1993 Jan; 211(1-2):19-26. PubMed ID: 7678805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site.
    Fairbrother WJ; Christinger HW; Cochran AG; Fuh G; Keenan CJ; Quan C; Shriver SK; Tom JY; Wells JA; Cunningham BC
    Biochemistry; 1998 Dec; 37(51):17754-64. PubMed ID: 9922141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.